This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Healthcare Stocks: Insulet (PODD), Crispr Therapeutics AG (CRSP)

Tipranks - Tipranks - Fri Jun 5, 5:16AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insulet (PODD) and Crispr Therapeutics AG (CRSP) with bullish sentiments.

Claim 55% Off TipRanks

Insulet (PODD)

In a report released today, Steven Lichtman from William Blair maintained a Buy rating on Insulet. The company’s shares closed last Wednesday at $143.30.

According to TipRanks.com, Lichtman is a 5-star analyst with an average return of 12.7% and a 50.5% success rate. Lichtman covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Sight Sciences, and Cooper Co. ;'>

Currently, the analyst consensus on Insulet is a Strong Buy with an average price target of $233.72, which is a 61.8% upside from current levels. In a report issued on May 22, TipRanks – OpenAI also upgraded the stock to Buy with a $172.00 price target.

See the top stocks recommended by analysts >>

Crispr Therapeutics AG (CRSP)

In a report released today, Sami Corwin from William Blair maintained a Buy rating on Crispr Therapeutics AG. The company’s shares closed last Wednesday at $52.08.

According to TipRanks.com, Corwin is a 5-star analyst with an average return of 17.4% and a 53.2% success rate. Corwin covers the Healthcare sector, focusing on stocks such as Kyverna Therapeutics, Inc., Allogene Therapeutics, and Aktis Oncology, Inc. ;'>

Crispr Therapeutics AG has an analyst consensus of Moderate Buy, with a price target consensus of $75.00.

Read More on PODD:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).